Maryland Tech & Science
Prolong Pharmaceuticals Announces Completion of Enrollment in Phase II Study of SANGUINATE® in the Treatment of Sickle Cell Disease Patients with Vaso-Occlusive Crisis in an Ambulatory Setting
13 12 2017
SOUTH PLAINFIELD, N.J., Dec. 13, 2017 -- Prolong Pharmaceuticals announced today that it has completed enrollment in its Phase II study to evaluate SANGUINATE® in the treatment of vaso-occlusive crisis in patients with sickle cell disease (SCD). SANGUINATE® is a first-in-class oxygen-delivery agent that is in development to treat localized and systemic hypoxia. Vaso-occlusive crisis (VOC) is a complication of sickle cell disease that results in severe, debilitating pain that impacts the quality of life for patients.
The Phase II study entitled, "A Phase II, Multicenter, Single-Blind, Randomized Study of the Safety and Effectiveness of SANGUINATE® Versus Normal Saline in Adult Sickle Cell Disease Patients With Vaso-Occlusive Crisis (VOC)" is a clinical study evaluating the safety and efficacy of SANGUINATE® for the treatment of VOC. The company expects data from all patients to be available in the first half of 2018. Preliminary results from a subset of patients were...
The Traffic Group’s Haberkam Named Federal Contracting Liaison Officer
13 12 2017
Renata Haberkam has been named as TTG’s Federal Contracting Liaison Officer in response to the firm earning the Service Disabled Veteran-Owned Small Business (SDVOSB) designation in October.
BALTIMORE December 13, 2017
The Traffic Group, Inc.’s (TTG) Renata Haberkam has been named as the firm’s Federal Contracting Liaison Officer. This appointment is in response to the firm earning the Service Disabled Veteran-Owned Small Business (SDVOSB) designation in October. The Traffic Group is one of the nation’s leading traffic engineering and transportation planning firms.
Haberkam also heads up The Traffic Group’s business development and marketing departments, and will retain her current title as Director of Business Development. She oversees firm’s marketing efforts, including the public relations program. Haberkam is active in the local chapters of the Society for Marketing Professional Services (SMPS) and Women’s Transportation Seminar (WTS). She is the immediate Past...
Baltimore, Maryland Reason #337 Why Joining the International .Well-Beyond. 'Marketing Network (#WellBeyond) Product May Be a Lousy Investment Idea
13 12 2017
Baltimore, MD -- 12/13/2017 -- Can APPS that go "Well-Beyond" really make apps that spread health?Can APPS that go "Well-Beyond" really make apps that spread happiness?Do you truly believe that APPS can be tools to help you live a better life?If You Do, then Contact Us [email protected] Develops Customs APPS.G3's latest APP Technology is called: Well-Beyond-Period (i.e. Well-Beyond.)What the APP? The word "app" is an abbreviation for "application." It's a piece of software that can run through a web browser or even offline on your computer, phone, tablet or any other electronic device. Apps may or may not have a connection to the internet. App is a modern take on the word software or application. This is why you probably only hear it in reference to a mobile app or a small piece of software that's running on a website. It's typically used to describe anything that isn't a full-fledged software program.Types of Apps: There are three main...
Pre-Market Technical Scan on Application Software Equities -- MINDBODY, Proofpoint, Trade Desk, and 2U Inc.
13 12 2017
NEW YORK, Dec. 13, 2017 --
In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has issued free tailored Stock Review on MB, PFPT, TTD, and TWOU which is a click away at http://www.wallstequities.com/registration. Ahead of today's trading session, WallStEquities.com presents for monitoring MINDBODY Inc. (NASDAQ: MB), Proofpoint Inc. (NASDAQ: PFPT), The Trade Desk Inc. (NASDAQ: TTD), and 2U Inc. (NASDAQ: TWOU). Application Software companies create, license, and sell software for a variety of uses, including personal and enterprise use. Many of these companies also sell complementary hardware. Get you free stock reports on these stock by registering now on Wall St. Equities at: http://www.wallstequities.com/registration
On Tuesday, shares in San Luis Obispo, California headquartered MINDBODY Inc. recorded a trading volume of 220,835 shares. The stock ended the session 1.29% lower at $30.55. The Company's shares...
The Council on Accreditation Recognizes Three Human Services Organizations as Winners of the 2017 Innovative Practices Award
13 12 2017
The Innovative Practices Award is presented by the Council on Accreditation (COA), an international accrediting body for human services organizations
The purpose of the Innovative Practices Award is to amplify the effect of one great idea by elevating it to the national stage and offering it as a resource for direct service providers, leadership, researchers, and advocates across the full spectrum of human services.
NEW YORK December 13, 2017
The Council on Accreditation (COA) has designated three of its accredited organizations as winners of the 2017 Innovative Practices Award.
The 2017 awardees are: Caroline County Department of Social Services - Re-Engaging Individuals through Successful Employment (RISE); GreenPath, Inc. - Building Successful Nonprofit/FinTech Partnerships; and The Children’s Village - Family Finding Program.
This year's evaluation process began with a preliminary round of submissions in which applicants provided a one-page synopsis of their innovative...
Marquis Who's Who Celebrates Lee Simon for Contributions to the Health Care Industry
13 12 2017
WEST NEWTON, MA, December 13, 2017 -- Dr. Lee Simon has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.Dr. Simon is the co-managing director of SDG, LLC, a firm whose role is to design strategies with pharmaceutical and device development companies to develop evidence of efficacy and safety to lead to regulatory approvals for commercial use. Over the course of his career consulting with the pharmaceutical industry, he has worked in both academic and regulatory capacities regarding pharmaceutical research and development. With an expertise in Federal Drug Administration guidelines, he has been in current role since 2006. From 2006 until 2012, he also acted as a consultant and member of the board of...
Judith Esther Karp, MD, Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's Who
13 12 2017
PALM DESERT, CA, December 13, 2017 -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to present Judith E. Karp, MD, with the Albert Nelson Marquis Lifetime Achievement Award. An accomplished listee, Judith Karp celebrates many years' experience in her professional network, and has been noted for achievements, leadership qualities, and the credentials and successes she has accrued in her field. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.Over the course of more than 40 years, Dr. Karp has honed her expertise in the field of oncology with specific focus on the pathogenesis, biology and investigational treatment of leukemia in adults. At the start of her career, she joined The Johns Hopkins...
Lockheed Martin's Long Range Anti-Ship Missile Marks Another Successful Flight Test
12 12 2017
ORLANDO, Fla., Dec. 12, 2017 -- Lockheed Martin (NYSE: LMT) successfully fired production-configuration Long Range Anti-Ship Missiles (LRASM) from a U.S. Air Force B-1B bomber.
During the test over the Sea Range at Point Mugu, California, B-1B aircrew simultaneously launched two LRASMs against multiple maritime targets, meeting the primary test objectives, including target impact.
Lockheed Martin successfully fired production-configuration Long Range Anti-Ship Missiles from a U.S. Air Force B-1B bomber. Photo credit: U.S. Navy.
"This continued success with LRASM provides confidence in its upcoming early operational capability milestone, putting a proven, unmatched munition into the U.S. Navy and U.S. Air Force inventories," said David Helsel, LRASM program director at Lockheed Martin Missiles and Fire Control. "The successful flight demonstrates LRASM's continued ability to strengthen sea control for our forces."
LRASM is designed to detect and destroy specific targets...
Roboteam Hosts Maryland Senator Chris Van Hollen
12 12 2017
GAITHERSBURG, Md.--(BUSINESS WIRE)--Roboteam Inc., the leading global provider of tactical ground robotic systems and controllers for defense, law enforcement and public safety missions – hosted Senator Chris Van Hollen on December 8 at its headquarters in Gaithersburg, Maryland. Senator Van Hollen met with Roboteam officials where they showcased their tactical ground robotics.
“Maryland is on the forefront of technological development and innovation, and I was able to see that firsthand during today’s visit to Roboteam,” said Senator Van Hollen. “Not only does Roboteam create good-paying Maryland jobs, the robotics they make are crucial to our Armed Forces. It was great to see the important work they’re doing and meet their dedicated team today.”
Senator Van Hollen's recent visit to Roboteam’s headquarters took place during a tour of Maryland-based businesses in Montgomery County, Maryland. During his visit, Senator Van Hollen met Roboteam’s predominantly military...
UPDATE: Future Farm Sets Closing Date for RI Building Zoned for Cannabis; Receives $1.4 Million in Warrant Conversions; and Provides Update on Voluntary Shareholder Warrant Conversion
12 12 2017
Vancouver, British Columbia, Dec. 12, 2017 --Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQB: FFRMF) is pleased to announce that the closing date for the previously announced acquisition of a 15,000 sq ft building in Providence, Rhode Island for $750,000 is set for January 15, 2018. The building is zoned to legally cultivate cannabis and, once licensed, will be used as a licensed medical marijuana cultivation space wholesaling to state-sanctioned dispensaries. The Company is also pleased to announce that $1.4 Million has been raised through the voluntary conversion of both its $0.35 and $0.37 warrants. Shareholders who have participated in the Company’s two offerings in 2017 and have not yet exercised their right to convert the warrants into FFT common stock can still purchase shares at the exercise price of $0.35 or $0.37 per share.The $0.35 per share warrants will expire and be worthless after January 11, 2018, which leaves 20 trading...
Live Traffic in Baltimore, MD